|
|
||||||||
ligands
1Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan Medical School, Ann Arbor 48109-0360; and 2Department of Pathology, Wayne State University School of Medicine, Detroit, Michigan 48201
Submitted 27 June 2003 ; accepted in final form 7 November 2003
Peroxisome proliferator-activated receptor-
(PPAR-
), a member of the nuclear hormone receptor family of ligand-dependent transcription factors, is a critical regulator of adipocyte differentiation and glucose metabolism. The expression, regulation, and functional significance of PPAR-
in alveolar macrophages (AMs), the predominant resident immune effector cell within the alveolus, have not been previously examined. In this study, we show that, in contrast to peritoneal macrophages, resident murine AMs constitutively express high levels of PPAR-
. Expression was primarily located in the nucleus by immunofluorescence staining. Quantitative real-time RT-PCR demonstrated that the predominant isoform was PPAR-
2. Expression of PPAR-
was induced by the anti-inflammatory cytokine IL-4. Treatment of murine AMs with PPAR-
ligands suppresses PMA-stimulated oxidative burst activity and LPS + IFN-
-mediated expression of inducible nitric oxide synthase. In addition, LPS-induced IL-12 mRNA and protein expression was inhibited by PPAR-
ligands. These results support an important immunomodulatory role for PPAR-
in AM responses.
15-deoxy-
12,14-prostaglandin J2; rosiglitazone; peroxisome proliferator-activated receptor-
2
This article has been cited by other articles:
![]() |
H. Gong, J. He, J. H. Lee, E. Mallick, X. Gao, S. Li, G. E. Homanics, and W. Xie Activation of the Liver X Receptor Prevents Lipopolysaccharide-induced Lung Injury J. Biol. Chem., October 30, 2009; 284(44): 30113 - 30121. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shinohara, T. Pantuso, S. Shinohara, M. Kogiso, Q. N. Myrvik, R. A. Henriksen, and Y. Shibata Persistent Inactivation of Macrophage Cyclooxygenase-2 in Mycobacterial Pulmonary Inflammation Am. J. Respir. Cell Mol. Biol., August 1, 2009; 41(2): 146 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tiesset, M. Pierre, J.-L. Desseyn, B. Guery, C. Beermann, C. Galabert, F. Gottrand, and M.-O. Husson Dietary (n-3) Polyunsaturated Fatty Acids Affect the Kinetics of Pro- and Antiinflammatory Responses in Mice with Pseudomonas aeruginosa Lung Infection J. Nutr., January 1, 2009; 139(1): 82 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Siracusa, J. J. Reece, J. F. Urban Jr., and A. L. Scott Dynamics of lung macrophage activation in response to helminth infection J. Leukoc. Biol., December 1, 2008; 84(6): 1422 - 1433. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Reddy, V. R. Narala, V. G. Keshamouni, J. E. Milam, M. W. Newstead, and T. J. Standiford Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-{gamma} Blood, November 15, 2008; 112(10): 4250 - 4258. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Milam, V. G. Keshamouni, S. H. Phan, B. Hu, S. R. Gangireddy, C. M. Hogaboam, T. J. Standiford, V. J. Thannickal, and R. C. Reddy PPAR-{gamma} agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L891 - L901. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Curtis, C. M. Freeman, and J. C. Hogg The Immunopathogenesis of Chronic Obstructive Pulmonary Disease: Insights from Recent Research Proceedings of the ATS, October 1, 2007; 4(7): 512 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saika, O. Yamanaka, Y. Okada, T. Miyamoto, A. Kitano, K. C. Flanders, Y. Ohnishi, Y. Nakajima, W. W.-Y. Kao, and K. Ikeda Effect of overexpression of ppar{gamma} on the healing process of corneal alkali burn in mice Am J Physiol Cell Physiol, July 1, 2007; 293(1): C75 - C86. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Standiford, V. G. Keshamouni, and R. C. Reddy Peroxisome Proliferator-activated Receptor-{gamma} as a Regulator of Lung Inflammation and Repair Proceedings of the ATS, October 1, 2005; 2(3): 226 - 231. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |